Skip to main content
. Author manuscript; available in PMC: 2018 Nov 20.
Published in final edited form as: J Med Chem. 2018 Oct 16;61(20):9316–9334. doi: 10.1021/acs.jmedchem.8b01248

Figure 2.

Figure 2.

Competitive-inhibition experiments via fluorescence anisotropy of SB-284851-BT (I) and analogues against BET bromodomains indicating selectivity for BET D1s. (A) IC50 values of analogues (means ± SEM) determined by competitive-fluorescence-anisotropy assays. Asterisks (*) indicate incomplete inhibition observed; ND indicates not determined. (B) Competition-binding isotherms of compounds IV and V against the first and second bromodomains of BRD4 and BRDT.